Numbness Clinical Trial
Official title:
Geranium Oil and Its Components for the Relief of Numbness-OB 100
This study is designed to evaluate the effectiveness of geranium oil and its components in the relief of numbness and the restoration of sensations.
| Status | Completed |
| Enrollment | 13 |
| Est. completion date | October 2011 |
| Est. primary completion date | October 2011 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - 18 years of age or older - Neuropathy with the inability to feel touch in a standard nylon filament test - Signed informed consent Exclusion Criteria: - Pregnant or nursing - Known allergies to geranium oil or geranium oil fractions - Open sore in the area of numbness - Migraine headaches or headaches to strong smells |
Endpoint Classification: Pharmacokinetics Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care
| Country | Name | City | State |
|---|---|---|---|
| United States | Penningto Biomedical Research Center | Baton Rouge | Louisiana |
| Lead Sponsor | Collaborator |
|---|---|
| Pennington Biomedical Research Center |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Response to numbness relief and restoration of sensation | 12 weeks | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03943498 -
Fingolimod in Treating Patients With Chemotherapy-Induced Neuropathy
|
Early Phase 1 | |
| Not yet recruiting |
NCT06450028 -
Lidocaine Versus Bupivacaine in Orthognathic Surgery
|
Phase 4 | |
| Recruiting |
NCT06094257 -
Prospective Study of Sensation and Satisfaction in Cancer and Transgender Mastectomy Patients
|
||
| Terminated |
NCT03206216 -
Feasibility Study of New Method of Diagnostic and Prediction of Painful CIPN
|
N/A | |
| Completed |
NCT02194036 -
Learning Oriented Physiotherapy - a New Approach
|
N/A |